No abstract available
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Breast Neoplasms* / drug therapy
-
Capecitabine / adverse effects
-
Female
-
Fluorouracil
-
Humans
-
Inflammatory Breast Neoplasms* / drug therapy
-
Lapatinib
-
Neoplasm Recurrence, Local / drug therapy
-
Receptor, ErbB-2
-
Trastuzumab
-
Treatment Outcome
Substances
-
Lapatinib
-
Capecitabine
-
Receptor, ErbB-2
-
Trastuzumab
-
Fluorouracil